Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price was up 21.2% on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares traded hands during trading, a decline of 46% from the average daily volume of 537,892 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a market cap of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32. The stock has a 50 day moving average price of C$0.11 and a two-hundred day moving average price of C$0.08.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Using the MarketBeat Dividend Yield Calculator
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- High Flyers: 3 Natural Gas Stocks for March 2022
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What is the Australian Securities Exchange (ASX)
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
